RXRX rallies past biotech ETFs as short interest, insider-sale filings shape coming week
Recursion Pharmaceuticals, Inc. closed Thursday at $3.80, gaining 13 cents as the U.S. markets wrapped up early for the holiday week. The stock traded 32.68 million shares, about double its 65-day average of 17.04 million. Nasdaq was closed Friday for Independence Day. RXRX outperformed major biotech names this week. From the June 26 close to July 2, RXRX gained 8.0%. The SPDR S&P Biotech ETF was up 3.3%. iShares Biotechnology ETF rose 4.5%. The SPDR S&P 500 ETF Trust added 2.2%.